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1. Introduction   
Since the initial use of prosthetic heart valves, the use of cardiac prosthesis and implantable 
devices has revolutionized the therapeutic options available to patients (de Oliveira et 
al.,2009). Cardiac Permanent PaceMakers (PPMs) have been implanted since the early 1960s. 
Over the past 50 years there have been tremendous advances in both the design of the 
device and the software employed. In the mid 1960s, transvenous leads were developed that 
could be inserted through a vein and thence into the heart, thus preventing the need for a 
thoracotomy. The development of ‘active fixation’ leads ensured a better contact with the 
endocardium and the presence of a steroid eluting tip helped to reduce any inflammation 
that might result. The introduction of the lithium iodine battery has dramatically increased 
the battery life to well over ten years. Radiofrequency programming became available in the 
1970s, allowing simple adjustments to be made to pacemaker’s settings without the need for 
surgery. Today, permanent pacemakers and ICD (Implantable Cardiac Defibrillator), 
together with any adjustments, can be completed within minutes using a portable computer. 
Information regarding events such as periods of bradycardia, tachycardia or ventricular 
fibrillation can be stored within the memory of the device and accessed by the specialist 
during the routine checkup. To maintain atrio-ventricular synchrony, dual chamber pacing 
was then introduced. Moreover, in the late 1990s, pacemaker technology had improved to 
the extent that it became possible to increase the pacing rate to match the patient’s activity 
level (Allen et al., 2007). 
A wide range of cardiac implantable electronic devices (CIEDs) are now available, including 
ICDs and cardiac resynchronization systems. PPMs are commonly used in patients with 
atrioventricular conduction block, sick sinus syndrome, and symptomatic sinus 
bradycardia, whereas ICDs target primarily patients at risk for life-threatening ventricular 
arrhythmias.  
Since clinical trials have consistently demonstrated the ability of the ICD to reduce 
mortality in selected patients with moderate-to-severe left ventricular systolic 
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dysfunction, the indications for CIEDs have expanded dramatically and the rate of 
implantation has greatly rosen. A recent analysis showed that rate of implantation in US 
between 1997 and 2004 rose by 19% and 60% for PPMs and ICDs, respectively. 
Approximately 70% of device recipients were 65 years of age or older, and more than 75% 
of them had one or more coexisting illnesses. The rate of ICD implantation has increased 
in the elderly (70 to 79 years of age) and very elderly (80 years of age or older). The 2001 
World Survey found that in developed countries, between 20% and 35% of CIED 
recipients were more than 80 years old. The National Hospital Discharge Survey found a 
49% increase in the number of new CIED implantations, including both PPMs and ICDs. 
In 2003, although the absolute number of PPMs implantations was higher than that of 
ICDs (180284 versus 57436 implanted devices) most of the increase in CIED device 
implantation was due to ICD implantations (160% and 31% increases in ICD and PPM 
implantations, respectively) (Baddour et al., 2010). 
Despite their unquestioned clinical importance and diffusion, CIEDs may be linked to 
several complications, including infections, and the consequences of them may be 
catastrophic. Therefore, development of strategies for the prevention of device associated 
infections is crucial (Borer et al., 2004).  
The reported rate of infection after implantation of permanent endocardial devices ranges 
between 0.13% and 12.6%, depending on definition. The wide use of CIEDs and increasing 
age of patients set the stage for higher role of associated infections and related 
hospitalizations increased of about 3-fold (Baddour et al., 2010). Moreover, the cost of 
treating device-associated infections may be enormous, thus leading to increased healthcare 
expenses (Borer et al., 2004). Precise data regarding the actual healthcare burden of CIED 
infections are not available. The financial impact is due to multiple factors, including the 
costs of device removal, cost of new device (which would be required in the majority of 
patients) and costs related to cardiac and other medical evaluations, diagnostic procedures, 
surgical interventions for infected device removal, medical therapy, and increased length of 
stay in intensive care unit (Baddour et al., 2010). 
2. Epidemiology of CIED associated infections   
CIED infections have been recognized as a source of major comorbidity since the early 
1970s. In earlier years, the rates of PPM infection ranged widely between 0.13% and 
19.9%. Although most infections have been limited to the pocket, frank PPM endocarditis 
accounted for approximately 10% of PPM infections. The decreased size of ICDs allowed 
implantation without thoracotomy. Initially, abdominal implantation with tunneling was 
required. Subsequently, the entire device could be implanted prepectorally; with these 
less extensive operations the infection rate lowered to less than 7%. In a study on all ICD 
primary implantations, replacements, and revisions at a single center, there were 21 ICD-
related infections (1.2%) among 1700 procedures. Among 959 patients with long-term 
follow-up, the infection rate was 3.2% with abdominal and 0.5% with pectoral systems 
respectively (Mela et al., 2001). However, globally, the rate of CIED infection has been 
increasing. Cabell et al. reported that the rate of cardiac device infections (PPMs, ICDs, 
valves, and ventricular assist devices) increased from 0.94 to 2.11 per 1000 patients 
between 1990 and 1999, a 124% increase during the study period. The rate of frank 
endocarditis was relatively unchanged (0.26 and 0.39 cases/1000 patients, respectively) 
(Cabell et al., 2004). These findings were similar to that analyzed in Olmsted County, 
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Minnesota, from 1975 to 2004. A total of 1524 patients were included with a total person-
time follow-up of 7578 years. The incidence of CIED infection was 1.9/1000 device years 
(95% confidence interval [CI] 1.1 to 3.1), with an incidence of pocket infection alone of 
1.37/1000 device-years (95% CI 0.62 to 0.75) and an incidence of pocket infection with 
bloodstream infection or device-related endocarditis of 1.14/1000 device-years (95% CI 
0.47 to 2.74) (Uslan et al., 2007). Notably, the cumulative probability of CIED infection was 
higher among patients with ICDs than among those with PPMs. The National Hospital 
Discharge Survey similarly showed that between 1996 and 2003, the number of 
hospitalizations for CIED infections increased 3.1-fold (2.8-fold for PPMs and 6.0-fold for 
ICDs). The numbers of CIED infection–related hospitalizations increased out of 
proportion to rates of new device implantation. Moreover, CIED infection increased the 
risk of in-hospital death by more than 2-fold (Voigt et al., 2006). 
3. Definition and clinical presentation  
CIED pocket infection is defined on the ground of signs and symptoms of local infection 
associated with microbiological confirmation based on results of cultures of 
intraoperatively collected fluid samples, explanted CIED, or purulent discharge from the 
pocket site. CIED infection can present as acute or chronic syndromes that can be both 
early or tardive. In the early, acute form, the short time elapsed between device 
implantation and occurrence of infection may prompt the diagnosis. In chronic and 
tardive infections there is often a delay between the onset of symptoms and the diagnosis. 
This may be due to the fact that CIED-related infections are not routinely considered in 
the differential diagnosis. In other cases, possible clues to the diagnosis are ignored. 
Clinical manifestations of pacemaker infection are linked to the portion of the device 
involved. Moreover, signs and symptoms may be limited to the insertion pocket or be 
systemic or absent altogether (Cacoub et al,. 1998). 
A CIED-related infection is considered nosocomial when occurs 48 hours after admission 
and is not incubating at the time of admission. Infection of CIED is regarded as health care 
associated if patient received intravenous therapy at home, attended an outpatient 
hemodialysis center in the previous 30 days, was hospitalized in an acute care hospital for 2 
days in the 90 days before admission, or resided in a nursing home or long-term care 
facility. In contrast, CIED-related infection is recognized as community acquired if it does 
not fit the above definitions (Tablan et al., 2003).  
3.1 Clinical presentation 
In the vast majority of cases, local inflammation of the generator-pocket site is present, 
including erythema (34%), pain (32%), swelling (21%), warmth (11.5%), and drainage 
through a fistulous or poorly healed incision (25%). In most severe cases cutaneous erosion 
(23%) with percutaneous exposure of the generator and/or leads may be seen. All these 
signs can be associated or not with bacteremia (Cacoub et al,. 1998). These local changes 
usually prompt medical attention. Some patients present with systemic symptoms that 
include malaise, fatigue, anorexia, or decreased functional capacity. Sometimes isolated 
local symptoms occurr without fever. Chua et al. reported the presence of localized signs 
without systemic involvement in 69% (88 of 123) of patients, a combination of local and 
systemic signs and symptoms in 20% (25 of 123), and systemic signs and symptoms alone in 
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11% (13 of 123) of patients (Chua et al., 2000).  In implanted patients with unexplained fever 
CIED associated endocarditis should be ruled out. In CIED recipient isolated bacteremia 
pro,t medical investigation to rolu out endocarditis. Pacemaker endocarditis should be 
considered in all patients with cardiac pacemakers and chronic fever, recurrent bronchitis, 
pulmonary infection, and recurrent or persistent pocket infection (Cacoub et al., 1998; Klug 
et al., 1997). In some patients, involvement of lungs may be evident, including pleural 
effusions, pneumonia, pulmonary abscess, recurrent pulmonary embolism. Recurrent 
bronchitis is evident in 32% to 43% of patients with pacemaker endocarditis. A serious 
complication of pacemaker infection is generator or lead erosion through the skin. This can 
be the consequence of primary infection or can be the result of pressure on the overlying 
tissue, resulting in erosion and subsequent contamination. Erosion has been noted to be 
more common after elective pacemaker replacement than initial implantation (Harcombe et 
al., 1998). Other rare conditions associated to CIED infections are thrombosis of a vein where 
leads were in place (subclavian vein or superior vena cava), symptomatic pulmonary 
embolism, septic arthritis, vertebral, sternal or femoral osteomyelitis, splenic, brain, liver 
and perinephric abscess (Sohail et al., 2007a). 
4. Pathophysiology  
4.1 Etiology 
In patients with pacemaker infection bacterial pathogens can be found in blood or 
pacemaker pockets. Pacemaker’s hardware can be colonized as well. The most common 
pathogens in pocket infections are skin flora, and, specifically, Staphylococcus aureus and 
coagulase-negative staphylococci, including Staphylococcus epidermidis. Rarely, enteric 
Gram-negative bacilli can be found. Repeated cultures and percutaneous aspirates should 
help make the distinction between normal skin flora and pathogenic culture isolates 
(Gandelman at al., 2007).  
Staphylococcal species cause most of CIED infections and account for 60%-80% of cases in 
most reported series (Fig.1). A variety of coagulase-negative Staphylococcus (CoNS) species 
have been described a causative agents of CIED infections. CoNS are a common cause of 
microbiological specimen contamination, and thus, repeated isolation of the same species of 
CoNS with an identical antibiotic susceptibility pattern is advisable to be diagnostic. 
Polymicrobial infection sometimes involves more than one species of CoNS. The prevalence 
of oxacillin resistance among staphylococcal strains has varied among studies ranging from 
4 to 22% (Sohail et al., 2007a; Viola et al., 2010). 
Several factors are responsible for the higher propensity of Staphylococci to cause CIED 
infections. Staphylococci are frequent colonizer of human skin and contamination of CIED 
generator, electrode leads or pocket tissue at the time of implantation is the predominant 
mechanism for the majority of the pocket infections. Staphylococci express on their 
membranes several adherence factors that enable them to bind the foreign materials and 
establish chronic infection. In addition, these organisms are capable of producing biofilm on 
the device surface which helps them to evade host defences and limit antimicrobial 
penetration. Finally, Staphylococci are the predominant pathogens responsible for 
secondary catheter-related bloodstream infections as they can seed the intravenous leads 
during an episode of bacteremia.    
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Corynebacterium species, Propionibacterium acnes, Gram-negative bacilli, including 
Pseudomonas aeruginosa, and Candida species account for a minority of CIED infections. 
Fungi other than Candida and nontuberculosis mycobacteria are rarely responsible for CIED 
infection (Sohail et al., 2010).  
The microorganisms that cause CIED infections may be acquired either endogenously from 
the skin of patients or exogenously from the hospital environment. An association has been 
found between the presence of preaxillary skin flora and the pathogens isolated from 
pacemaker infection. Although low concentrations of methicillin-resistant CoNS have been 
detected in patients with no previous healthcare contact and no recent antibiotic exposure, a  
CIED infection due to multidrug-resistant staphylococci suggests that a healthcare 
environment is the site where infection was acquired (Da Costa et al., 1998a).  
Pacemaker endocarditis usually presents with bacterial growth in both blood and 
hardware cultures. Although there is no uniform agreement regarding the rate of positive 
blood cultures in pacemaker endocarditis, S. epidermidis and S. aureus occur most 
frequently. Other pathogens include Corynebacterium sp., Pseudomonas aeruginosa, and 
Aspergillus niger. In one study, polymicrobial infections were found in 18.1% (Cacoub et 
al., 1998).  
 
 
Fig. 1. Microbiology of CIED infection. Modified from Baddour et al., 2010. 
4.2 Pathogenesis 
The generator is placed within a surgically created space known as pocket. Electrode 
leads are attached to the generator and travel within the venous system to the right heart. 
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Pacemaker infection can be limited to the superficial portion of the pocket and leads or 
involve deeper intravascular and intracardiac components. The latter is known as 
pacemaker endocarditis. Among patients with pacemaker endocarditis, vegetations can 
occur on the tricuspid valve, the electrodes, and the right atrial or ventricular 
endocardium.  
The pocket may become infected at the time of implantation, during subsequent surgical 
manipulation, or if the generator or subcutaneous electrodes erode the overlying skin. In 
this latter case, erosion can also occur as a secondary event due to underlying infection. 
Pacemaker endocarditis can be linked to several factors, including pacemaker lead 
contamination during placement, spread of the organisms along the wires from the 
superficial component, or hematogenous seeding of the intravascular electrodes and wires 
during a bacteriemic episode. While Gram-posivie bacteriamias can cause CIED infections, 
hematogenous seeding of a CIED is unlikely to occur in cases of Gram-negative bacteremia. 
The disruption of the physiologic blood flow through the tricuspid valve often caused by a 
pacing lead passing through the valve and associated regurgitation may contribute to 
pacemaker infection. Microbial adherence to endothelium has been shown to increase in 
areas of high shear turbulence (Baddour et al., 2010).  
CIED infection is the result of the interaction between the device, the microbe, and the host.  
4.2.1 Devices factors  
Initial adhesion of bacteria to the device is mediated by physico-chemical properties of the 
plastic surface, such as hydrophobicity, surface tension, and electrostatic charge.  
Factors like the nature of plastic polymer, irregularity of its surface, and its shape, can all 
affect bacterial adherence to the device. Plastic polymers that encase medical devices, as well 
as the pathogens that adhere to them, are hydrophobic. An irregularly surfaced device 
favours microbial adherence more than a smoothed surfaced one. When this physiochemical 
interaction exists, the risk of CEID infection is related to subsequent invasive manipulation 
of the device and may be linked to a limited experience of the physician performing the 
procedure (Darouiche, 2001).   
4.2.2 Microbial factors  
Bacteria, particularly Gram-positive cocci, can adhere to and be engulfed by endothelial cells 
that lie on endothelialized lead after a certain period of time. This is thought to be an 
important mechanism of device infection by the hematogenous route.  
Microbial adherence may be linked also to interactions of bacterial surface with proteins on 
device’s surface. CoNS may adhere directly to plastic polymers of the surface of the device 
via fimbria-like surface protein structures or via a capsular polysaccharide (Veenstra et al., 
1996). Bacteria may also adhere to host matrix proteins that coat the surface of an implanted 
device. Host extracellular matrix proteins include fibrinogen, fibronectin, and collagen that 
are layered on implanted biomaterials. None of the major virulence factors or toxins of S 
Aureus have been found in CoNS, and it seems clear that the development and persistence 
of CoNS infections, which are so often associated with foreign materials, are due to different 
mechanisms, such as microbiological adherence. On the contrary, Staphylococci have a 
variety of surface adhesins that allow the pathogen to establish a focus of infection.  
 
Subsequent accumulation of bacteria on the device’s surface requires the production of 
polysaccharide intercellular adhesin, which is strongly linked to with the staphylococcal cell 
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surface and mediates cell-to-cell adhesion. The layers of bacteria on the surface of an 
implanted device are encased in this extracellular slime and constitute a biofilm. Biofilm is 
defined as a surface-associated community of one or more microbial species that are firmly 
attached to each other and the solid surface and are encased in an extracellular polymeric 
matrix that holds the biofilm together. Bacteria in a biofilm are more resistant to antibiotics 
and host defences, perhaps as a result of the dense extracellular matrix that protects the 
microbes included in the interior of the community (Lazăr & Chifiriuc, 2010). When a free-
floating bacterial cell enters the biofilm, it undergoes a phenotypic shift, in which expression 
of large groups of genes is up-regulated. Phenotypic variation is thought to support the 
persistence of infection due to staphylococci in a biofilm that coats the surface of a CIED. 
Small colony variants are phenotypes that have caused CIED infections and harbor several 
characteristics that are thought to enhance the survival of staphylococci either in a biofilm or 
in endothelial cells covering the device, including resistance to certain antibiotics (Baddour 
et al., 1990; Boelens et al., 2000). 
4.3 Risk factors 
Several studies have identified host or procedural factors that may be associated with CIED 
infections.  
Among the host factors, the strongest association is between renal failure and risk of CIED 
infection. Risk of device infection appears to be particularly high in patient with end-stage 
renal failure who are undergoing chronic hemodialysis via an implanted central catheter. 
These patients are at risk of recurrent bacteremia from their dialysis catheter and subsequent 
secondary seeding of the tranvenous device leads or pulse generator. Renal failure is also 
associated with immune dysfunction that further increases the odd of CIED infections in 
these patients (Bloom et al.,2006). 
Anticoagulant therapy with warfarin has also been linked to a higher risk of CIED 
infection. Precise reasons for this association are unclear but are likely related to the 
increased risk of pocket hematoma, which may lead to delayed wound healing or need for 
surgical drainage in some cases. Reopening the pocket to drain a large hematoma 
increases the risk of pocket contamination with skin flora and subsequent CIED infection 
(Lekkerkerker et al., 2009).  
Use of immunosuppressive medications, especially long term corticosteroids therapy, has 
also been identified as a risk factor for CIED infections (Sohail et al., 2007b).  
Procedure-related factors may also play an important role in the development of CIED 
infections. In a prospective cohort of 6319 patients receiving CIED implantation in 44 
medical centers, Klug et al. identified 42 patients who developed CIED infection during 1 
year of follow-up. Factors associated with an increased risk of infection included fever 
within 24 hours before implantation, use of preprocedural temporary pacing, and early 
reintervention. Implantation of a new system compared with partial or complete system 
replacement and use of periprocedural antimicrobial prophylaxis were both associated with 
a lower risk of infection (Klug et al., 2007). There is evidence that perioperative antimicrobial 
prophylaxis is associated with a reduction in CIED infections (Bertaglia et al., 2006; Da Costa 
et al., 1998b; de Oliveira et al., 2009).  
Other small studies suggest that pectoral transvenous device placement is associated with 
significantly lower rates of CIED infection than those implanted abdominally or by 
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thoracotomy. Thus, the use of a pectoral approach is not only less invasive but also appears 
to confer an ancillary benefit of lower infection risk (Mela et al., 2001). 
Physician experience in CIED implantation may also play a role in the rate of subsequent 
CIED infection. In a study of Medicare administrative data, Al-Khatib et al. found a 
significantly higher risk of ICD infection within 90 days of device implantation in patients 
whose device was placed by physicians in the lowest quartile of implantation volume. Rates 
of mechanical complications at 90 days were also higher for lower-volume physicians (Al-
Khatib et al., 2005). 
5. Diagnosis  
5.1 Clinical and microbiological diagnosis 
In all patients with suspected CIED infection diagnosis is linked to both local and systemic 
signs of inflammation associated to positive microbiological culture of the skin pocket or 
other materials. Signs and symptoms of systemic inflammation include malaise, fever with 
or without chill, leucocytosis and, in most severe cases, hypotension. A new onset valvular 
murmur suggests CIED endocarditis. Local signs of infection include redness and oedema 
and pain of the skin pocket. 
Definitive diagnosis of CIED infection is linked to microbiological cultures. Usually, samples 
are taken from the generator pocket. Alternatively, once the device has been removed, 
samples from lead tips may be cultured to identify the causative organism and support a 
diagnosis of CIED infection. Gram staining, anaerobic and aerobic bacterial cultures, should 
all be performed. If the initial Gram stain is negative, both tissue and the lead tip should be 
cultured for fungi and mycobacteria. Percutaneous aspiration of the device pocket is not 
recommended because of its low diagnostic accuracy and the theoretical risk of introducing 
microorganisms into the pocket site or spreading germ into the blood stream. 
Contamination of leads may also occur at the time of their extraction throught a contamined 
skin pocket; this may explain some of the positive lead-tip cultures found in patients 
without systemic manifestation and with negative blood cultures. If a CIED-related 
endocarditis is suspected, at least two sets of blood cultures should be obtained before 
starting any antimicrobial therapy. Positive blood cultures, particularly due to 
staphylococcal species, provide a strong clue that the clinical syndrome is due to CIED 
infection (Baddour et al., 2010).  
5.2 Instrumental diagnosis 
5.2.1 Transthoracic and transesophageal echocardiography 
Endocarditis is clinically confirmed when valvular or lead neostructures consistent  
with vegetations are detected on echocardiography, or if the Duke criteria for  
infective endocarditis are met (Table 1)(Klug et al., 1997, Durak et al. 1994). Vegetation is 
defined as an oscillating intracardiac mass which can be seen on the electrodes, the  
leads or the cardiac valve leaflets. To be diagnostic, vegetation should be noted in more 
than one echocardiographic plane (Klug et al., 1997; Sanfilippo et al., 1991; Victor et al., 
1999). Both transtoracic echocardiography (TTE) and transesophageal echocardiography 
(TEE) may be employed, even though TEE is more accurate and is the actual gold 
standard.  
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Definite infective endocarditis 
Pathological criteria 
Microorganisms: demonstrated by culture or histology in vegetation, in a vegetation 
that has embolized, or in intracardiac abscess, or demonstrated by culture of the lead 
Clinical criteria  
Two major criteria, or one major and three minor criteria, or five minor criteria 
 Major criteria 
  Positive blood culture for infective endocarditis 
  Typical microorganisms for infective endocarditis from two separate 
  blood cultures 
  Streptococcus viridans, Streptococcus bovis, HACEK group, or 
  Community-acquired Staphylococcus aureus or enterococci, in the 
  absence of a primary focus, or 
  Persistently positive blood culture, defined as microorganism  
  consistent with infective endocarditis from 
  Blood cultures drawn >12 hours apart, or 
  All of three or a majority of four or more separate blood cultures, 
  with first and last drawn at least 1 hour apart 
  Evidence of endocardial involvement: 
  Positive echocardiogram for infective endocarditis: 
  Oscillating intracardiac mass on PM leads or on the endocardial 
  structure in contact with PM leads 
  Abscess in contact with PM leads 
 Minor criteria 
  Fever >38°C 
  Vascular phenomena: arterial embolism, septic pulmonary infarcts, 
  mycotic aneurysm, intracranial hemorrhage, Janeway lesions 
  Immunologic phenomena: glomerulonephritis, Osler nodes, Roth 
  spots 
  Echocardiogram: consistent with infective endocarditis but not 
  meeting major criterion as noted previously (sleevelike appearance) 
  Microbiological evidence: positive blood culture but not meeting 
  major criterion as noted previously 
Table 1. Diagnostic criteria for infective endocarditis. Modified from Durak et al., 1994. 
TTE is not helpful in ruling out a diagnosis of lead-related endocarditis, particularly in 
adults, due to its poor sensitivity. Moreover, patients can develop both right-sided (lead-
related) and left-sided endocarditis. Actually, sensitivity of TTE for left-sided and for 
perivalvular extension of infection is lower than TEE. On the contrary several indirect 
echocardiographic features of endocarditis may be better seen with TEE. They include 
pericardial effusion, ventricular dysfunction or dyssynchrony, and pulmonary vascular 
pressure estimations. TEE may be not always available and can be discomfortable for the 
patients. For these reasons, even if TEE rapresents the gold standard for the diagnosis of 
CIED infections, and is recommended for the initial diagnosis, TTE can be used during the 
course of patient’s illness for additional studies or follow-up. It is important to underlyine 
that an echocardiographyc image of a mass adherent to the lead may be a sterile thrombus 
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or infected vegetation and it is impossible to distinguish between the two with 
echocardiography. Masses that are detected in patients without positive blood cultures or 
other signs of infection are likely to sterile vegetation (thrombus).  In addition, the failure to 
visualize a mass adherent to a lead with TEE does not exclude lead infection. Thus, even 
when vegetation is demonstrated, differential diagnosis may be difficult if microbiological 
culture are not positive. Clear guidelines for CIED infection diagnosis are lacking. Based on 
clinical practice and expert opinion, a summary of recommendations for diagnosis of CIED 
infections is provided in Table 2.  
 
Class I 
1. All patients should have at least 2 sets of blood cultures drawn at the initial evaluation 
before initiation of antimicrobial therapy. (Level of Evidence: C) 
2. Generator-pocket tissue Gram’s stain and culture and lead-tip culture should be 
obtained when the CIED is explanted. (Level of Evidence: C)
3. Patients with suspected CIED infection who either have positive blood cultures or who 
have negative blood cultures but have had recent antimicrobial therapy before blood 
cultures were obtained should undergo TEE for CIED infection or valvular endocarditis. 
(Level of Evidence: C) 
4. All adults suspected of having CIED-related endocarditis should undergo TEE to 
evaluate the left-sided heart valves, even if transthoracic views have demonstrated lead-
adherent masses. In pediatric patients with good views, transthoracic echocardiography 
may be sufficient. (Level of Evidence: B)
 
Class IIa 
Patients should seek evaluation for CIED infection by cardiologists or infectious disease 
specialists if they develop fever or bloodstream infection for which there is no initial 
explanation. (Level of Evidence: C) 
 
Class III 
Percutaneous aspiration of the generator pocket should not be performed as part of the 
diagnostic evaluation of CIED infection. (Level of Evidence: C) 
Table 2. Recommendations for Diagnosis of CIED Infection and Associated Complications. 
Modified from Baddour et al., 2010. 
5.2.2 Positive Emission Tomography (PET) 
Infection staging and identification of other septic locations may be very important in order 
to monitor treatment efficacy before any re-implantation. It might be useful to assess the 
extension of infectious disease (staging) in these patients by non-invasive whole-body 
imaging, and Fluoro-18 desoxyglucose (18F-FDG) PET is a potential candidate for this 
purpose. The use of 18F-FDG PET imaging in inflammatory processes is related to the high 
affinity of inflammatory cells such as neutrophils, lymphocytes and macrophage for 18F-
FDG. 18F-FDG PET shows high diagnostic accuracy when infection affects the box of 
generator but is slightly less reliable when the leads are involved. Globally, sensitivity and 
specificity are optimal for box infection even if mild physiological uptake may be seen in 
normal cases. Physiologically, a slight 18F-FDG uptake may be observed around the box 
even in not infected patients, particularly in the area of the muscle interface. However, 
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uptake around the box is much higher in case of infection. Leads infection represents a 
different challenge. The size of the leads and the size of the vegetation are both very small 
and may easily be below the theoretical resolution of the PET system. For leads, sensitivity 
and specificity are lower, and diagnosis is based upon visualization of mild focal uptake 
along the leads. Interpretation of negative cases should be cautious, particularly if patients 
have received prolonged antibiotherapy (Bensimhon et al., 2010). 
6. Prevention  
The significant morbidity and mortality associated with device infections and the need for 
device removal make prevention of infections extremely important. Prevention of CIED 
infection can be addressed before, during, and after device implantation. Before implanting 
intravascular devices, it is important to ensure that patients do not have clinical signs of 
infection. In this case definitive implantation should be posponed after the resolution of 
infection. Once CIEDs are implanted, both pharmacological and non pharmacological 
strategies can be adopted in order to reduce risk of infection. 
6.1 Pharmacological strategies 
A meta-analysis of 7 randomized studies on 2023 patients examining the impact of systemic 
antibiotics on the risk of pacemaker-related infections suggested that systemic antibiotic 
prophylaxis significantly reduces the incidence of serious infective complications after 
pacemaker implantation (Da Costa et al., 1998b). A following observational study was 
performed to assess the safety and long-term efficacy of a simple scheme of antibiotic 
prophylaxis, and to identify the predictors of long-term infective complications in patients 
undergoing pacemaker implantation or replacement. This study showed the efficacy of a 
single dose of cefazolin in preventing infective complications (Bertaglia et al., 2006). Finally 
a prospective, randomized, double-blinded, placebo-controlled trial was developed to 
determine whether prophylactic antibiotic administration reduces the incidence of infection 
related to device implantation was. This double blinded study included 1000 consecutive 
patients who presented for primary device implantation or generator replacement 
randomized in a 1:1 fashion to prophylactic antibiotics or placebo. Intravenous 
administration of 1 g of cefazolin or placebo was done immediately before the procedure. 
Follow-up was performed at 10 days and 1, 3, and 6 months after discharge. The primary 
end point was any evidence of infection at the surgical incision (pulse generator pocket), or 
systemic infection related to the procedure. The safety committee interrupted the trial after 
649 patients were enrolled because of a significant difference in favor of the antibiotic arm 
and concluded that antibiotic prophylaxis significantly reduces infectious complications in 
patients undergoing implantation of pacemakers or cardioverter-defibrillators (de Oliveira 
et al., 2009). Most experts continue to advocate a first-generation cephalosporin, such as 
cefazolin, as prophylaxis agent. Although not generally recommended, some authors 
advocate the use of vancomycin, particularly in centers where oxacillin resistance among 
staphylococci is high. If vancomycin is used, then it should be administered 90 to 120 
minutes before the procedure. Vancomycin also represents an alternative to a first-
generation cephalosporin in patients who are allergic to cephalosporins (Sohail et al., 2007b). 
In patients who are allergic to both cephalosporins and vancomycin, daptomycin and 
linezolid are alternative agents for prophylaxis. Antibiotic prophylaxis is also recommended 
if subsequent invasive manipulation of the CIED is required. Currently, there are no data to 
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support the administration of postoperative antibiotic therapy, and this is not recommended 
because of the risk of drug adverse events, selection of drug-resistant organisms, and costs 
(Baddour et al., 2010).  
6.2 Non pharmacological strategies 
Several preventive measures are recommended in combination with prophylactic 
antibiotics. Using a strictly aseptic technique during implantation is of paramount 
importance, including surgical scrubbing, use of standard operating room, facemasks, caps, 
and sterile gowns and gloves, and the use of sterile, dry gauze pads to cover surgical 
incisions (Voet et al., 1999). Other preventive strategies include to limit the duration of 
temporary pacing to the shortest time and to limit the number of people in the room during 
the procedure to those absolutely necessary. Prevention of hematoma during the procedure 
is important, and several interventions have been used, although there are no data to 
support their use (Lekkerkerker et al., 2009). This can be achieved by meticulous 
cauterization of bleeding sites and packing the pocket with antibiotic-soaked sponges to 
provide tamponade while leads are being placed. The application of topical thrombin may 
be helpful, particularly in anticoagulated patients. Irrigation of the pocket is useful to 
remove debris and may reveal persistent bleeding that could lead to a pocket hematoma. In 
addition, irrigation with an antimicrobial-containing solution for pocket cleansing has been 
used. Use of monofilament suture for closure of the subcuticular layer may avoid superficial 
postoperative cellulitis. A compressive dressing applied 12-24 hours after skin closure may 
further decrease the risk of hematoma formation. In the immediate postoperative period, 
recent data indicate that low-molecular-weight heparin predisposes to hematoma formation 
and should be avoided (Robinson et al., 2009). A hematoma should be evacuated only when 
there is increased tension on the skin. Needle aspiration should otherwise be avoided 
because of the risk of introducing skin flora into the pocket and subsequent development of 
infection. Finally, routine ambulatory care follow-up after CIED placement to detect early 
infectious complications has been performed in many centers and this is actively 
recommended (Deuling et al., 2009). 
7. Therapy  
7.1 Conservative treatment 
Optimal management of CIED infection depends on the clinical presentation and causative 
pathogen. Conservative treatment with antibiotics alone without removal of the device may 
be sufficient in patients with local signs without sepsis, endocarditis or skin erosion. Seven 
to ten days of antibiotic therapy with an oral agent with activity against staphylococci is 
reasonable (Gandelman et al., 2007).  
7.2 Device removal 
Complete removal of all hardware is the recommended treatment for patients with 
established CIED infection or sepsis (Chua et al., 2000; Sohail et al., 2007a). This includes 
cases in which a localized pocket infection occurs in the absence of signs of systemic 
infection. Complete removal of hardware is needed because infection relapse rates due to 
retained hardware are high (Field et al., 2007). Erosion of any part of the CIED should imply 
contamination of the entire system, including the intravascular portion of leads, and 
complete device removal should be performed. Complete CIED removal should be 
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performed when patients undergo valve replacement or repair for infective endocarditis, 
because the CIED could serve as a nidus for relapsing infection and subsequent seeding of 
the surgically treated heart valve. An epicardial system should be considered if a new CIED 
is required after valve surgery with initial CIED removal. Device removal is also 
recommended in those patients with S. aureus bacteremia with clinical or echocardiographic 
evidence of CEID infection, un-explained bacteremia, or relapsing bacteremia after antibiotic 
treatment (Chamis et al., 2001).  
7.2.1 Approach to hardware removal 
Two techniques for removing pacemaker systems are currently available: invasive 
thoracotomy and percutaneous extraction. The choice of the less invasive percutaneous 
technique is usually based on time elapsed from implantation, vegetation size, absence of 
vegetation on the tricuspid valve, and the general conditions of the patient. Percutaneous 
lead extraction has become the preferred method for removal of CIED hardware. However, 
these procedures involve significant risks, including cardiac tamponade, hemothorax, 
pulmonary embolism, lead migration, and death, even in experienced hands. Thus, the 
performance of these procedures should be limited to centers with the appropriate facilities 
and training, including the presence of immediate availability of cardiothoracic surgery to 
provide backup in the event of complications. In high-volume centers, percutaneous lead 
removal can be accomplished relatively safely with a high rate of success (Jones et al., 2008). 
A primary surgical approach to lead removal in patients with CIED infection should be 
limited to patients who have significant retained hardware after one attempt at 
percutaneous removal. Another scenario in which a preference for surgical lead removal has 
been advocated is in patients with lead vegetations >2 cm in diameter, because of concerns 
about the risk of pulmonary embolism with percutaneous lead extraction. Experience 
suggests, however, that percutaneous removal in patients with large vegetations can be 
done without precipitating a clinically apparent pulmonary embolism. Until additional data 
are available, decisions regarding percutaneous versus surgical removal of leads with 
vegetations larger than 2 cm in diameter should be individualized and based on a patient’s 
clinical parameters and the extractor’s evaluation (Field et al., 2007; Gandelman et al., 2007; 
Sohail et al., 2007a).  
Antimicrobial therapy is adjunctive in patients with CIED infection, and complete device 
removal should not be delayed, regardless of timing of initiation of antimicrobial therapy. 
Selection of the appropriate antimicrobial agent should be based on identification and in 
vitro susceptibility testing results. Because most infections are due to staphylococcal species, 
treatment agent should be effective against those germs. In case of oxacillin resistant 
infections is suspected, vancomycin should be administered initially as empirical antibiotic 
coverage until microbiological results are known. Patients with infections due to oxacillin-
susceptible staphylococcal strains can be given cefazolin or nafcillin alone with 
discontinuation of vancomycin. Vancomycin should be continued in patients who are not 
candidates for betalactam antibiotic therapy and those with infections due to oxacillin-
resistant staphylococci. Compared with Gram-positive infections, Gram-negative and fungi 
are less frequently isolated and empiric coverage against those microorganisms is not 
routinely indicated; it should be started after microbiological identification has been 
performed.  
Pathogen identification and in vitro susceptibility testing can be used to guide treatment in 
patients with nonstaphylococcal CIED infections. When microbiological culture are 
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available, a de-escalation approach should be considered in order to minimize the 
development of antimicrobial resistances (De Gaudio et al., 2010). There are no clinical trial 
data to define the optimal duration of antimicrobial therapy for CIED infections, regardless 
of the extent of infection, or to determine when conversion to an oral agent is appropriate 
once complete device removal has been achieved. Factors that influence duration of therapy 
include the extent of device infection, the causative organism, the persistence of positive 
blood cultures, and associated complications such as valvular involvement, septic 
thrombophlebitis, or osteomyelitis. Blood cultures should be obtained from all patients after 
device removal. Therapy can be switched to an oral regimen once susceptibility results are 
known if there is an oral agent available that is active against the pathogen and the infected 
CIED has been removed. At least two weeks of parenteral therapy are recommended after 
removal of an infected device and for patients with bloodstream infection. Patients with 
sustained (>24 hours) positive blood cultures despite CIED removal and appropriate 
antimicrobial therapy should receive parenteral therapy for at least 4 weeks, even if TEE is 
negative for valvular vegetations.  
7.2.2 Hardware reimplantation 
It is important to assess the need for new device placement in any patient with an infected 
CIED. Based of available data, one third to one half of patients will not require new CIED 
placement. There are several factors, including reversal of the pathological processes that 
precipitated the need for CIED implantation and lack of appropriate clinical indications, that 
may obviate the need for new CIED placement (Sohail et al., 2007b). Adequate debridement 
and control of infection at all sites, both at the generator site and metastatic, if present, must 
be achieved before new device placement (Baddour et al., 2010). Removal of infected 
hardware should not be attempted until a careful assessment of a new implantation strategy 
has been performed, particularly in patients with pacemakers for complete heart block and 
resynchronization therapy devices. When implantation of a new device is necessary, it 
should be performed on the counterlateral side if possible to avoid relapsing device 
infection. If this is not possible, a transvenous lead can be tunneled to a device placed 
subcutaneously in the abdomen. Implantation is usually postponed to allow for resolution 
of infection, but patients who are CIED dependent represent a challenge, because they 
cannot be discharged with a temporary pacemaker. Active-fixation leads attached to pacing 
generators or defibrillators are now being used as a bridge until PPM implantation is 
deemed appropriate. Use of active-fixation leads connected to external devices permits 
earlier mobilization of patients dependant on cardiac stimulators and has been associated 
with a reduced risk of pacing-related adverse events, including lead dislocation, and local 
infection (Braun et al., 2006). 
Optimal timing of device replacement is unknown. There have been no prospective trials 
that examined timing of new device replacement and risk of relapsing infection; however, 
several investigators recommend waiting for blood cultures to be negative before a new 
device is placed (Gandelman et al., 2007; Sohail et al., 2007a) 
8. Conclusions  
Currently, 3 million implanted cardiac pacing systems and 180000 implantable cardioverter-
defibrillators exist worldwide. The rate of device implantations is increasing due to the 
aging of the general population and the development of new indications. Although 
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conferring obvious benefits, the use of these implantable devices is associated with some 
complications. Infections must be considered as a serious and potentially fatal complication.  
The clinical presentation of device infection ranges from superficial wound infection to 
frank device-related endocarditis.  
The incidence of infection related to pacemakers varies from 0.13% to 19.9% in prospective 
and retrospective studies. Serious complications, such as endocarditis and sepsis, may occur 
in 0.5% of patients. In addition, infectious complications have a significant economic impact 
to health care systems due to the high cost of treatment. 
Data to guide treatment of patients with this condition are limited. However, the consensus 
from the published literature recommends prompt and complete device removal, combined 
with antimicrobial therapy of appropriate duration. Conservative treatment without 
explantation of all hardware is frequently unsuccessful. Given the progressive rise in 
antimicrobial-resistant bacteria in general, and gram-positive pathogens in particular, 
treatment of cardiovascular infections is likely to become more difficult in the future. 
Finally, because a substantial number of patients may no longer require such devices, 
reimplantation should be done only after the continued need for such therapy has been 
reassessed.   
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